JPMorgan stock jumps as Wall Street rallies on Venezuela shock; payrolls and earnings in focus
5 January 2026
1 min read

JPMorgan stock jumps as Wall Street rallies on Venezuela shock; payrolls and earnings in focus

New York, Jan 5, 2026, 11:02 EST — Regular session

  • JPMorgan shares rise about 3.4% in late morning trade, outpacing the broader market.
  • Financial stocks lead a Wall Street rally sparked by weekend geopolitical news tied to Venezuela.
  • Traders are watching Friday’s U.S. jobs report and JPMorgan’s Jan. 13 earnings for the next catalyst.

JPMorgan Chase & Co. shares climbed about 3.4% to $336.70 in late morning trade on Monday, after swinging between $323.56 and $336.70 earlier in the session. The stock closed Friday at $325.48.

The gains came as Wall Street’s main indexes rallied after a U.S. military strike that captured Venezuelan President Nicolas Maduro, sending energy and financial stocks higher. “With the markets taking geopolitics in stride so far, the first trading week of the New Year may likely revolve around whether tech will find its footing,” Chris Larkin, managing director for trading and investing at E*TRADE at Morgan Stanley, wrote in a note. 1

For JPMorgan investors, the move matters because the bank sits at the crossroads of two forces that can reset valuations fast: risk appetite and interest rates. When traders lean into “risk-on” bets, bank shares often move with the broader push into cyclicals.

Rate expectations are a second lever. Markets are pricing roughly 60 basis points of Federal Reserve easing this year — basis points are hundredths of a percentage point — and any shift in that path can ripple quickly into financials. 1

Banks tend to do better when longer-term yields rise relative to short-term rates, because that can widen the spread between what they earn on loans and what they pay on deposits. A flatter curve squeezes that spread, which is why Friday’s jobs data has the sector’s attention.

That focus sharpens with JPMorgan set to report fourth-quarter and full-year 2025 results on Jan. 13, with the release scheduled for about 7:00 a.m. ET and a conference call at 8:30 a.m. ET, the bank said. 2

Investors will be listening for updates on net interest income — the difference between interest earned and interest paid — along with expense discipline, credit quality and any signals on capital returns such as share buybacks.

Monday’s advance in JPMorgan tracked a broader push in financials, with gains also seen in Goldman Sachs and American Express, according to Reuters. 1

The risk is that the day’s catalyst fades. If geopolitical optimism reverses or oil-related expectations cool — while U.S. sanctions on Venezuelan oil remain in place — the rally in cyclicals could unwind.

Traders will also watch whether JPMorgan can hold above the $330 level after breaking higher early in the session, a move that can matter for short-term positioning.

Next up is Friday’s U.S. nonfarm payrolls report, followed by JPMorgan’s earnings on Jan. 13 — the two events most likely to set the tone for bank stocks into mid-January. 1

Stock Market Today

Disney stock ends week higher after Friday bounce — what to watch for DIS next week

Disney stock ends week higher after Friday bounce — what to watch for DIS next week

7 February 2026
Disney shares closed up 3.6% at $108.70 Friday, recovering from earlier losses as U.S. stocks rallied and the Dow topped 50,000. Investors are watching Super Bowl streaming economics and Disney’s CEO transition, with Josh D’Amaro set to take over at the March 18 meeting. Disney reported quarterly revenue of $25.98 billion and adjusted EPS of $1.63, while segment operating income fell 9% to $4.6 billion.
Novo Nordisk stock: Class B shares face Monday test after FDA squeeze forces Hims to pull $49 Wegovy copycat

Novo Nordisk stock: Class B shares face Monday test after FDA squeeze forces Hims to pull $49 Wegovy copycat

7 February 2026
Novo Nordisk Class B shares closed up 5.3% at 295.50 Danish crowns in Copenhagen after Hims & Hers said it would stop offering a compounded pill version of Wegovy following U.S. regulatory warnings. The move came after Novo called the Hims product “illegal mass compounding” and threatened legal action. Shares had fallen nearly 8% Thursday after Hims launched the pill. Trading resumes Monday.
Linde stock price falls as LIN heads into weekend; JPMorgan downgrade and guidance in focus

Linde stock price falls as LIN heads into weekend; JPMorgan downgrade and guidance in focus

7 February 2026
Linde plc shares fell 2.5% to $448.24 Friday after reporting Q4 sales up 6% to $8.76 billion and adjusted EPS of $4.20. The company guided 2026 adjusted EPS to $17.40–$17.90, below analyst consensus. JPMorgan downgraded the stock, while Morgan Stanley and UBS raised price targets. Linde repurchased $1.4 billion in shares in Q4 and returned $7.4 billion to shareholders in 2025.
Energy Fuels stock jumps as uranium names heat up again — what’s driving UUUU today
Previous Story

Energy Fuels stock jumps as uranium names heat up again — what’s driving UUUU today

Sandisk stock rises as AI memory shortage talk lifts SNDK; earnings date looms
Next Story

Sandisk stock rises as AI memory shortage talk lifts SNDK; earnings date looms

Go toTop